Inflammation and adverse cardiovascular outcome in patients with renal artery stenosis and peripheral artery disease

Atherosclerosis

Volumn 205, Issue 1, 2009, Pages 314-318

  Schlager, Oliver ^a   Amighi, Jasmin ^a   Haumer, Markus ^a   Sabeti, Schila ^a   Dick, Petra ^a   Mlekusch, Wolfgang ^a   Loewe, Christian ^a   Koppensteiner, Renate ^a   Minar, Erich ^a   Schillinger, Martin ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Atherosclerosis; Outcome; Peripheral vascular disease; Renal

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ACUTE KIDNEY FAILURE; ADULT; AGED; ANGIOPLASTY; ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; BYPASS SURGERY; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; HEART INFARCTION; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; INFLAMMATION; KIDNEY ANGIOGRAPHY; KIDNEY ARTERY STENOSIS; LIMB AMPUTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; STROKE;

AGED; ANGIOPLASTY; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CREATININE; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PROSPECTIVE STUDIES; RENAL ARTERY OBSTRUCTION; TREATMENT OUTCOME;

EID: 67349100619     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.12.022     Document Type: Article

References (31)

1. Lusis A.J. Atherosclerosis. Nature 407 6801 (2000) 233-241
2. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 340 (1999) 115-126
3. Libby P., Ridker P., and Maseri A. Inflammation and atherosclerosis. Circulation 105 (2002) 1135-1143
4. Glass C.K., and Witztum J.L. Atherosclerosis: the road ahead. Cell 104 (2001) 503-516
5. Ridker P.M., Rifai N., Rose L., Buring J.E., and Cook N.R. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347 (2002) 1557-1565
6. Tracy R.P., Lemaitre R.N., Psaty B.M., et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol 17 (1997) 1121-1127
7. Ridker P.M., Hennekens C.H., Buring J.E., and Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342 (2000) 836-843
8. Danesh J., Whincup P., Walker M., et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 321 (2000) 199-204
9. Albert C.M., Ma J., Rifai N., Stampfer M.J., and Ridker P.M. Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death. Circulation 105 (2002) 2595-2599
10. Ridker P.M., Stampfer M.J., and Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 285 (2001) 2481-2485
11. Schillinger M., Exner M., Amighi J., et al. Joint effects of C-reactive protein and glycated hemoglobin in predicting future cardiovascular events in patients with advanced atherosclerosis. Circulation 108 (2003) 2323-2328
12. Schillinger M., Exner M., Mlekusch W., et al. Inflammation and carotid artery risk for atherosclerosis study (ICARAS). Circulation 111 (2005) 2203-2209
13. Schlager O., Exner M., Mlekusch W., et al. C-reactive protein predicts future cardiovascular adverse events in patients with carotid stenosis. Stroke 38 4 (2007) 1263-1268
14. Schillinger M., Exner M., Mlekusch W., et al. Serum albumin predicts cardiac adverse events in patients with advanced atherosclerosis-interrelation with traditional cardiovascular risk factors. Thromb Haemost 91 2 (2004) 610-618
15. Mui K.W., Sleeswijk M., van den Hout H., van Baal J., Navis G., and Woittiez A.J. Incidental renal artery stenosis is an independent predictor of mortality in patients with peripheral vascular disease. J Am Soc Nephrol 17 (2006) 2069-2074
16. Conlon P.J., Athirakul K., Kovalik E., et al. Survival in renal vascular disease. J Am Soc Nephrol 9 (1998) 252-256
17. Conlon P.J., Little M.A., Pieper K., and Mark D.B. Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography. Kidney Int 60 (2001) 1490-1497
18. Iglesias J.I., Hamburger R.J., Feldman L., and Kaufman J.S. The natural history of incidental renal artery stenosis in patients with aortoiliac vascular disease. Am J Med 109 (2000) 642-647
19. Leertouwer T.C., Pattynama P.M., and Van den Berg-Huysmans A. Incidental artery stenosis in peripheral vascular disease: a case for treatment?. Kidney Int 59 (2001) 1480-1483
20. Menon V., Greene T., Wang X., et al. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney Int 68 2 (2005) 766-772
21. Stuveling E.M., Hillege H.L., Bakker S.J., Gans R.O., De Jong P.E., and De Zeeuw D. C-reactive protein is associated with renal function abnormalities in a non-diabetic population. Kidney Int 63 2 (2003) 654-661
22. Park J.S., Park J.H., Kang J.Y., et al. Hyperfibrinogenemia is an independent risk factor for atherosclerotic renal artery stenosis. Am J Nephrol 19 6 (1999) 649-654
23. Rundback J.H., Sacks D., Kent K.C., et al. AHA Councils on Cardiovascular Radiology, Blood Pressure Research, Kidney in Cardiovascular Disease, Cardio-Thoracic and Vascular Surgery, and Clinical Cardiology, and the Society of Interventional Radiology FDA device forum committee. American Heart Association. Guidelines for the reporting of renal artery revascularization in clinical trials. American Heart Association. Circulation 106 (2002) 1572-1585
24. Stuveling E.M., Hillege H.L., Bakker S.J., et al. C-reactive protein and microalbuminuria differ in their association with various domains of vascular disease. Atherosclerosis 172 (2004) 107-114
25. Dzielinska Z., Januszewicz A., Demkow M., et al. Cardiovascular risk factors in hypertensive patients with coronary artery disease and coexisting renal artery stenosis. J Hypertens 25 3 (2007) 663-670
26. Fried L.F., Shlipak M.G., Crump C., et al. Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals. J Am Coll Cardiol 41 (2003) 1364-1372
27. Manjunath G., Tighiouart H., Ibrahim H., et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol 41 (2003) 47-55
28. Weiner D.E., Tighiouart H., Amin M.G., et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 15 (2004) 1307-1315
29. Panichi V., Migliori M., De Pietro S., et al. The link of biocompatibility to cytokine production. Kidney Int Suppl 76 (2000) S96-S103
30. Verhave J.C., Hillege H.L., Burgerhof J.G., et al. The association between atherosclerotic risk factors and renal function in the general population. Kidney Int 67 5 (2005) 1967-1973
31. Shlipak M.G., Fried L., Crump C., et al. Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 107 (2003) 87-92